Dennis Matheis

CIK: 0001817012

Transaction Breakdown

Open Market Buys (P)6 (54.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)1 (9.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

DRIO

DarioHealth Corp.

Director

LUCD

Lucid Diagnostics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

DRIO
DarioHealth Corp.
Sep 24, 2026
Award(A)
Direct
44K shares-
DRIO
DarioHealth Corp.
Jul 23, 2026
Purchase(P)
Direct
14.4K shares at avg. $6.93$100K
LUCD
Lucid Diagnostics Inc.
May 20, 2026
Purchase(P)
Direct
245K shares at avg. $1.00$245K
LUCD
Lucid Diagnostics Inc.
Feb 20, 2026
Award(A)
Direct
123K shares-
DRIO
DarioHealth Corp.
Sep 11, 2025
Award(A)
Direct
20K shares-
LUCD
Lucid Diagnostics Inc.
Aug 20, 2025
Purchase(P)
Direct
100K shares at avg. $1.02$102K
LUCD
Lucid Diagnostics Inc.
May 22, 2025
Purchase(P)
Direct
33.2K shares at avg. $1.32$44K
LUCD
Lucid Diagnostics Inc.
May 21, 2025
Purchase(P)
Direct
129.7K shares at avg. $1.32$172K
LUCD
Lucid Diagnostics Inc.
May 20, 2025
Purchase(P)
Direct
187.1K shares at avg. $1.29$242K
LUCD
Lucid Diagnostics Inc.
Feb 20, 2025
Award(A)
Direct
112.8K shares-
DRIO
DarioHealth Corp.
Aug 12, 2024
Conversion(C)
Direct
965 shares at avg. $19.10$18K

		Type	Shares	Price		Ownership
Sep 24, 2026	DRIO DarioHealth Corp.	Award(A)	44,000	-	$0	Direct
Jul 23, 2026	DRIO DarioHealth Corp.	Purchase(P)	14,430	$6.93	$100,000	Direct
May 20, 2026	LUCD Lucid Diagnostics Inc.	Purchase(P)	245,000	$1.00	$245,270	Direct
Feb 20, 2026	LUCD Lucid Diagnostics Inc.	Award(A)	123,000	-	$0	Direct
Sep 11, 2025	DRIO DarioHealth Corp.	Award(A)	20,000	-	-	Direct
Aug 20, 2025	LUCD Lucid Diagnostics Inc.	Purchase(P)	100,000	$1.02	$101,840	Direct
May 22, 2025	LUCD Lucid Diagnostics Inc.	Purchase(P)	33,218	$1.32	$43,795	Direct
May 21, 2025	LUCD Lucid Diagnostics Inc.	Purchase(P)	129,684	$1.32	$171,520	Direct
May 20, 2025	LUCD Lucid Diagnostics Inc.	Purchase(P)	187,098	$1.29	$242,292	Direct
Feb 20, 2025	LUCD Lucid Diagnostics Inc.	Award(A)	112,800	-	-	Direct
Aug 12, 2024	DRIO DarioHealth Corp.	Conversion(C)	965	$19.10	$18,432	Direct

1-11 of 11 transactions

About Matheis Dennis

Matheis Dennis (SEC CIK 0001817012) files insider reports with the SEC as Director of DarioHealth Corp. (DRIO) and Director of Lucid Diagnostics Inc. (LUCD).

Signal8 holds 9 ownership filings by Matheis Dennis, all Form 4s, filed between Feb 21, 2025 and Sep 28, 2026. Those filings report 11 transactions, from Aug 12, 2024 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Matheis Dennis's filings is in NEW YORK, NY.

Recent filings by Matheis Dennis

Sep 24, 2026: Grant or award of DRIO shares (Form 4, code A).
Jul 23, 2026: Open-market purchase of DRIO shares (Form 4, code P).
May 20, 2026: Open-market purchase of LUCD shares (Form 4, code P).
Feb 20, 2026: Grant or award of LUCD shares (Form 4, code A).
Sep 11, 2025: Grant or award of DRIO shares (Form 4, code A).

Other insiders filing for DarioHealth Corp. (DRIO)

PALUMBO JOHN R, Director
STERN ADAM K, Director
MCGRATH DENNIS M, Director
Shaked Yoav, Director
Franco-Yehuda Chen, Chief Financial Officer
Karah Hila, Director

How to read Form 4 transaction codes